These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37093351)

  • 1. A regional anticoagulation program improves safety and outcomes for both children and adults.
    Rodriguez V; Stanek J; Cua CL; Sankar A; Giver J; Monda K; Canini J; Dunn AL; Kerlin BA
    J Thromb Thrombolysis; 2023 Jul; 56(1):27-36. PubMed ID: 37093351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation of cardiomyopathy in children.
    Monagle K; Jones S; King I; Weintraub R; Monagle P; Newall F
    Thromb Res; 2014 Aug; 134(2):255-8. PubMed ID: 24867812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS; Batchelor K; Bua J; Newall F
    Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating time in therapeutic range for hemodialysis patients taking warfarin.
    Quinn LM; Richardson R; Cameron KJ; Battistella M
    Clin Nephrol; 2015 Feb; 83(2):80-5. PubMed ID: 25500296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
    Bernstein MR; John L; Sciortino S; Arambages E; Auletta D; Spyropoulos AC
    J Thromb Thrombolysis; 2020 Feb; 49(2):316-320. PubMed ID: 31898275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
    Wallentin L; Yusuf S; Ezekowitz MD; Alings M; Flather M; Franzosi MG; Pais P; Dans A; Eikelboom J; Oldgren J; Pogue J; Reilly PA; Yang S; Connolly SJ;
    Lancet; 2010 Sep; 376(9745):975-83. PubMed ID: 20801496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of using portable coagulation monitor for INR examination after left-sided mechanical prosthetic valve replacement.
    Shen Y; Zhong FX; Huang XS
    J Cardiothorac Surg; 2022 Dec; 17(1):297. PubMed ID: 36471365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of warfarin dosage fluctuation with time in therapeutic range for bleeding or thromboembolism rate in Chinese patients.
    Yu HY; Tsai HE; Chen YS; Hung KY
    J Formos Med Assoc; 2019 Feb; 118(2):611-618. PubMed ID: 30126761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    Vestergaard AS; Skjøth F; Larsen TB; Ehlers LH
    PLoS One; 2017; 12(11):e0188482. PubMed ID: 29155884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.
    Barta AL; Nutescu EA; Thompson PA; Bussey HI; Gulseth MP
    Am J Health Syst Pharm; 2015 Jul; 72(14):1188-94. PubMed ID: 26150568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry.
    Lehto M; Niiranen J; Korhonen P; Mehtälä J; Khanfir H; Hoti F; Lassila R; Raatikainen P
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):657-665. PubMed ID: 28317274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care.
    Ha NB; Yang K; Hanigan S; Kurtz B; Dorsch MP; Mak H; Nagel J
    Ann Pharmacother; 2016 Sep; 50(9):734-40. PubMed ID: 27317014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Internet-Based Warfarin Anticoagulation Management Approach After Mechanical Heart Valve Replacement: Prospective, Multicenter, Randomized Controlled Trial.
    Zhu Z; Li C; Shen J; Wu K; Li Y; Liu K; Zhang F; Zhang Z; Li Y; Han J; Qin Y; Yang Y; Fan G; Zhang H; Ding Z; Xu D; Chen Y; Zheng Y; Zheng Z; Meng X; Zhang H
    J Med Internet Res; 2021 Aug; 23(8):e29529. PubMed ID: 34397393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.